Breaking News Instant updates and real-time market news.

OGEN

Oragenics

$0.51

0.0792 (18.42%)

, XON

Intrexon

$31.21

0.02 (0.06%)

15:31
11/21/16
11/21
15:31
11/21/16
15:31

Oragenics says FDA grants Fast Track designation to AG013

Oragenics (OGEN) announced that the U.S. FDA granted Fast Track designation to AG013, the company's lead therapeutic candidate for the treatment of OM. Oragenics expects to file an Investigational New Drug update and initiate a Phase 2 study with AG013 in the United States and Europe in early 2017. AG013 is an ActoBiotics therapeutic candidate formulated as a convenient oral rinsing solution and designed by Intrexon (XON) to deliver the therapeutic molecule Trefoil Factor 1 to the mucosal tissues in the oral cavity. Trefoil Factors are a class of peptides involved in protection of gastrointestinal tissues against mucosal damage and have an important role in subsequent repair. In addition to this Fast Track designation, AG013 has already been granted Orphan Drug status in the European Union. Under an Exclusive Channel Collaboration Agreement with Intrexon, Oragenics has an exclusive worldwide license to develop and commercialize AG013 to treat oral mucositis in cancer patients.

OGEN

Oragenics

$0.51

0.0792 (18.42%)

XON

Intrexon

$31.21

0.02 (0.06%)

OGEN Oragenics
$0.51

0.0792 (18.42%)

XON Intrexon
$31.21

0.02 (0.06%)

05/03/16
05/03/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wal-Mart (WMT) initiated with an Underperform at RBC Capital due to a negative risk/reward ratio, citing the company's massive size, intensifying competition and the shift towards e-commerce. 2. Costco (COST) initiated with an Outperform at RBC Capital with the firm saying that the company's membership fees provide it with "a growing, high margin revenue stream," while it has " some of the best/most consistent customer traffic growth in all of retail." 3. Kroger (KR) initiated with a Neutral at SunTrust. 4. H&R Block (HRB) initiated with a Neutral at Sterne Agee CRT. 5. Intrexon (XON) initiated with an Outperform at JMP Securities by analyst Jason Butler, who said Intrexon has a "highly scalable" business model and has achieved technological and regulatory validation in the areas of food, health, and the environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/11/16
STFL
05/11/16
NO CHANGE
Target $57
STFL
Buy
Intrexon appears to be making incremental progress, says Stifel
Stifel analyst Thomas Shrader acknowledges that Intrexon's Q1 results press release and associated call were "highly complex" and the stock remains "highly polarizing," but he believes the company is making incremental progress, that the potential deployment of its mosquitoes to combat Zika seems to be advancing, and noted that its gas to liquid bioconversion programs were reported to be in the "red zone" of development. The company appears to be increasingly focused on non-therapeutic and non-medical projects and Shrader continues to view its gas to liquid energy conversion program as the highest value opportunity at Intrexon, he told investors in a post-earnings research note. The firm keeps a Buy rating and $57 price target on Intrexon shares.
07/15/16
JMPS
07/15/16
NO CHANGE
Target $42
JMPS
Outperform
JMP says ZIOPHARM trial death doesn't read through to other Intrexon programs
JMP Securities analyst Jason Butler said he views the patient death in ZIOPHARM's (ZIOP) Ad-RTS-IL-12 GBM trial as "possibly or even likely due to the study drug" and acknowledges the need for caution regarding the potential safety concerns of Ad-RTS-IL-12. However, while the trial death raises questions, Butler contends it has no read through to partner Intrexon's (XON) broader oncology programs. The analyst, who notes there are multiple other programs in or entering the clinic under the collaborations between ZIOPHARM and Intrexon, keeps an Outperform rating and $42 price target on Intrexon shares.
09/08/16
JMPS
09/08/16
NO CHANGE
JMPS
Intrexon could benefit from Zika eradication efforts, says JMP Securities
JMP Securities analyst Jason Butler notes that a bipartisan group of Florida House members and the leaders of the state's Pinellas County asked the federal government to grant a waiver that would allow the use of Intrexon's Friendly Aedes for Zika eradication efforts. The analyst says that a waiver could result in "nearer term government orders." He keeps a $42 price target and Outperform rating on Intrexon.

TODAY'S FREE FLY STORIES

BHI

Baker Hughes

$65.40

1.4 (2.19%)

13:02
12/02/16
12/02
13:02
12/02/16
13:02
Hot Stocks
Baker Hughes reports U.S. rig count up 4 to 597 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DAL

Delta Air Lines

$48.38

0.61 (1.28%)

12:56
12/02/16
12/02
12:56
12/02/16
12:56
Hot Stocks
Ned Walker to return to Delta as chief communications officer »

John "Ned"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$32.06

-1.7901 (-5.29%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$28.99

0.465 (1.63%)

12:55
12/02/16
12/02
12:55
12/02/16
12:55
Conference/Events
MGM Resorts participates in a luncheon meeting hosted by the National Press Club »

James Murren, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

VASC

Vascular Solutions

12:48
12/02/16
12/02
12:48
12/02/16
12:48
Downgrade
Vascular Solutions rating change  »

Vascular Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/02/16
12/02
12:45
12/02/16
12:45
General news
Breaking General news story  »

Week of 12/2 Baker-Hughes…

NUS

Nu Skin

$50.75

0.52 (1.04%)

12:44
12/02/16
12/02
12:44
12/02/16
12:44
Conference/Events
Nu Skin to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

, IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

12:41
12/02/16
12/02
12:41
12/02/16
12:41
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week total flows…

SPY

SPDR S&P 500 ETF Trust

$219.77

0.1999 (0.09%)

IVV

iShares Core S&P 500

$221.02

0.29 (0.13%)

XOP

SPDR Oil Exploration and Production Fund

$41.98

-0.075 (-0.18%)

FXR

First Trust Industrials/Producer Durables AlphaDEX Fund

$33.03

0.0144 (0.04%)

GLD

SPDR Gold Trust

$112.20

0.6635 (0.59%)

IAU

iShares Gold Trust

$11.34

0.07 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

12:40
12/02/16
12/02
12:40
12/02/16
12:40
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

, JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

12:34
12/02/16
12/02
12:34
12/02/16
12:34
Periodicals
Actelion's silence speaks volumes to hedge funds, Reuters says »

Actelion's (ALIOF)…

ALIOF

Actelion

$190.80

-5.45 (-2.78%)

JNJ

Johnson & Johnson

$111.93

0.55 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.51

0.0018 (0.35%)

, BSX

Boston Scientific

$20.33

0.235 (1.17%)

12:31
12/02/16
12/02
12:31
12/02/16
12:31
Recommendations
Neovasc, Boston Scientific analyst commentary  »

Neovasc's Boston…

NVCN

Neovasc

$0.51

0.0018 (0.35%)

BSX

Boston Scientific

$20.33

0.235 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

FE

FirstEnergy

$30.62

-0.37 (-1.19%)

12:30
12/02/16
12/02
12:30
12/02/16
12:30
Options
Flurry of activity in First Energy puts »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

IBERIABANK

$84.15

1.3 (1.57%)

12:26
12/02/16
12/02
12:26
12/02/16
12:26
Upgrade
IBERIABANK rating change  »

IBERIABANK upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

12:20
12/02/16
12/02
12:20
12/02/16
12:20
General news
Treasury Option Action: and now some bullish call buying »

Treasury Option Action:…

PBIB

Porter Bancorp

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp says court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/02/16
12/02
12:16
12/02/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is light for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
12/02/16
12/02
12:15
12/02/16
12:15
General news
Breaking General news story  »

Federal Reserve Gov.…

PBIB

Porter Bancorp

12:13
12/02/16
12/02
12:13
12/02/16
12:13
Hot Stocks
Porter Bancorp announces appellate court affirms ruling »

Porter Bancorp, parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$58.51

0.54 (0.93%)

, WDAY

Workday

$71.33

-10.275 (-12.59%)

12:12
12/02/16
12/02
12:12
12/02/16
12:12
General news
On The Fly: Top stock stories at midday »

Stocks opened with modest…

SBUX

Starbucks

$58.51

0.54 (0.93%)

WDAY

Workday

$71.33

-10.275 (-12.59%)

ULTA

Ulta Beauty

$257.41

-2.09 (-0.81%)

P

Pandora

$12.58

1.095 (9.54%)

SIRI

Sirius XM

$4.56

-0.015 (-0.33%)

BX

Blackstone

$25.82

-0.33 (-1.26%)

GM

General Motors

$35.75

-0.6802 (-1.87%)

JPM

JPMorgan

$81.22

-0.57 (-0.70%)

BLK

BlackRock

$372.34

-4.86 (-1.29%)

DIS

Disney

$98.47

-0.4661 (-0.47%)

WMT

Wal-Mart

$70.74

0.0662 (0.09%)

IBM

IBM

$159.48

-0.342 (-0.21%)

INFO

IHS Markit

$35.11

-0.83 (-2.31%)

ASNA

Ascena Retail

$5.83

-0.21 (-3.48%)

FIVE

Five Below

$39.88

0.52 (1.32%)

AMBA

Ambarella

$61.39

-0.13 (-0.21%)

SWHC

Smith & Wesson

$23.98

0.65 (2.79%)

ATI

Allegheny Technologies

$16.05

-1.71 (-9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 08

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

SOHO

Sotherly Hotels

$5.48

-0.01 (-0.18%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Hot Stocks
Sotherly Hotels announces $10M stock repurchase program »

Sotherly Hotels announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$7.65

-0.09 (-1.16%)

12:10
12/02/16
12/02
12:10
12/02/16
12:10
Options
Fiat Chrysler Dec 7 - 8 call spread at 64c, 4K on ISE »

Fiat Chrysler Dec 7 - 8…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

PBIB

Porter Bancorp

12:07
12/02/16
12/02
12:07
12/02/16
12:07
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Porter Bancorp trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.80

-0.26 (-1.62%)

12:02
12/02/16
12/02
12:02
12/02/16
12:02
Periodicals
Deutsche Bank to cease some coverage for about 3,400 clients, WSJ says »

Deutsche Bank plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

OZM

Och-Ziff Capital

$3.14

0.18 (6.08%)

12:01
12/02/16
12/02
12:01
12/02/16
12:01
Hot Stocks
Och-Ziff Capital advances after AUM increased in November »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.